GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SCL Science Inc (XKRX:246960) » Definitions » Research & Development

SCL Science (XKRX:246960) Research & Development : ₩1,231 Mil (TTM As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is SCL Science Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. SCL Science's Research & Development for the three months ended in Mar. 2024 was ₩298 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ₩1,231 Mil.


SCL Science Research & Development Historical Data

The historical data trend for SCL Science's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SCL Science Research & Development Chart

SCL Science Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 958.36 1,238.71 1,423.22 1,337.95 1,235.24

SCL Science Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 301.44 351.89 329.95 251.96 297.56

SCL Science Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩1,231 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SCL Science  (XKRX:246960) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


SCL Science Research & Development Related Terms

Thank you for viewing the detailed overview of SCL Science's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


SCL Science (XKRX:246960) Business Description

Traded in Other Exchanges
N/A
Address
Seonyu-ro 13-gil, ACE Hitech City 2, 25, Number 1209, Yeongdeungpo-gu, Seoul, KOR, 07282
InnoTherapy Inc is a South-Korea based medical device company. It has developed a technology to control physical property of bio-inspired by the adhesive properties of living organisms. The products offered by the company include InnoSEAL, EndoSil and GellySil among others.

SCL Science (XKRX:246960) Headlines

No Headlines